These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30478682)

  • 1. Postoperative Skeletal Muscle Loss Predicts Poor Prognosis of Adenocarcinoma of Upper Stomach and Esophagogastric Junction.
    Kudou K; Saeki H; Nakashima Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
    World J Surg; 2019 Apr; 43(4):1068-1075. PubMed ID: 30478682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor size predicts worse prognosis in esophagogastric junction adenocarcinoma.
    Takeda FR; Ramos MFKP; Pereira MA; Sallum RAA; Ribeiro Junior U; Nahas SC; Cecconello I
    Updates Surg; 2022 Dec; 74(6):1871-1879. PubMed ID: 35776245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative development of sarcopenia is a strong predictor of a poor prognosis in patients with adenocarcinoma of the esophagogastric junction and upper gastric cancer.
    Kudou K; Saeki H; Nakashima Y; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Nakanishi R; Kubo N; Ando K; Oki E; Ikeda T; Maehara Y
    Am J Surg; 2019 Apr; 217(4):757-763. PubMed ID: 30005807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study.
    Kim KW; Lee K; Lee JB; Park T; Khang S; Jeong H; Ko CS; Yook JH; Kim BS; Lee IS
    BMC Cancer; 2021 Feb; 21(1):157. PubMed ID: 33579228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Sarcopenia in Patients with Esophagogastric Junction Cancer or Upper Gastric Cancer.
    Kudou K; Saeki H; Nakashima Y; Edahiro K; Korehisa S; Taniguchi D; Tsutsumi R; Nishimura S; Nakaji Y; Akiyama S; Tajiri H; Nakanishi R; Kurashige J; Sugiyama M; Oki E; Maehara Y
    Ann Surg Oncol; 2017 Jul; 24(7):1804-1810. PubMed ID: 28224363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of advanced adenocarcinomas of esophagogastric junction and distal stomach in Japanese patients.
    Kawano A; Nakajima TE; Oda I; Hokamura N; Iwasa S; Kato K; Hamaguchi T; Yamada Y; Fujii H; Shimada Y
    Gastric Cancer; 2014 Jan; 17(1):54-60. PubMed ID: 23435842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in Japan.
    Abe S; Ishihara R; Takahashi H; Ono H; Fujisaki J; Matsui A; Takahashi A; Goda K; Kawada K; Koike T; Takeuchi M; Tsuji Y; Hirasawa D; Oyama T
    Gastrointest Endosc; 2019 Jun; 89(6):1120-1128. PubMed ID: 30576649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal Muscle Loss After Esophagectomy Is an Independent Risk Factor for Patients with Esophageal Cancer.
    Nakashima Y; Saeki H; Hu Q; Tsuda Y; Zaitsu Y; Hisamatsu Y; Ando K; Kimura Y; Oki E; Mori M
    Ann Surg Oncol; 2020 Feb; 27(2):492-498. PubMed ID: 31549319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer.
    Kudou K; Saeki H; Nakashima Y; Kamori T; Kawazoe T; Haruta Y; Fujimoto Y; Matsuoka H; Sasaki S; Jogo T; Hirose K; Hu Q; Tsuda Y; Kimura K; Ando K; Oki E; Ikeda T; Maehara Y
    J Gastroenterol Hepatol; 2019 Feb; 34(2):355-363. PubMed ID: 30119141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Endoscopic Submucosal Dissection for Adenocarcinoma of the Esophagogastric Junction.
    Gong EJ; Kim do H; So H; Ahn JY; Jung KW; Lee JH; Choi KD; Song HJ; Lee GH; Jung HY; Kim JH
    Dig Dis Sci; 2016 Sep; 61(9):2666-73. PubMed ID: 27112341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediastinal lymph node dissection and distal esophagectomy is not essential in early esophagogastric junction adenocarcinoma.
    Lee IS; Ahn JY; Yook JH; Kim BS
    World J Surg Oncol; 2017 Jan; 15(1):28. PubMed ID: 28100248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma.
    Jiang DM; Suzuki C; Espin-Garcia O; Lim CH; Ma LX; Sun P; Sim HW; Natori A; Chan BA; Moignard S; Chen EX; Liu G; Swallow CJ; Darling GE; Wong R; Jang RW; Elimova E
    Cancer Med; 2020 May; 9(9):3023-3032. PubMed ID: 32130793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy.
    Gianotti L; Braga M; Landoni L; Mari G; Scaltrini F; Di Castelnuovo A; Di Carlo V
    Hepatogastroenterology; 2003; 50(54):1948-52. PubMed ID: 14696439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
    J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What to do after R1-resection of adenocarcinomas of the esophagogastric junction?
    Gertler R; Richter J; Stecher L; Nitsche U; Feith M
    J Surg Oncol; 2016 Sep; 114(4):428-33. PubMed ID: 27333949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.
    Yamashita H; Seto Y; Sano T; Makuuchi H; Ando N; Sasako M;
    Gastric Cancer; 2017 Mar; 20(Suppl 1):69-83. PubMed ID: 27796514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.